Intravenous access is rarely necessary in food protein-induced enterocolitis syndrome oral food challenges

TY - JOUR

T1 - Intravenous access is rarely necessary in food protein-induced enterocolitis syndrome oral food challenges

AU - Patel, Gaytri

AU - Crain, Maria

AU - Bird, J. Andrew

AU - Parrish, Christopher P.

N1 - Funding Information: Conflists of disclosure: J.A. Bird reports consultancy with Allergenis, Allergy Therapeutics, Before Brands, DBV Technologies, Genentech, Aimmune Therapeutics, and Novartis; and receives grant funding to his institution from Aimmune, DBV Technologies, Genentech, the National Institutes of Health-National Institute of Allergy and Infectious Diseases, Novartis, Siolta, and Regeneron. C.P. Parrish reports receiving research support funds to his institution from the National Institutes of Health-National Institute of Allergy and Infectious Diseases, Regeneron Pharmaceuticals, and DBV Technologies; travel expenses from DBV Technologies; consulting fees from Magellan Rx; and speaking fees from Sanofi Genzyme; and has been a part of advisory boards for Sanofi Genzyme and Takeda Pharmaceuticals, all outside this work. The rest of the authors declare that they have no relevant conflicts of interest.

PY - 2023/12

Y1 - 2023/12

UR - http://www.scopus.com/inward/record.url?scp=85168848267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85168848267&partnerID=8YFLogxK

U2 - 10.1016/j.jaip.2023.07.049

DO - 10.1016/j.jaip.2023.07.049

M3 - Article

C2 - 37579876

AN - SCOPUS:85168848267

SN - 2213-2198

VL - 11

SP - 3792-3794.e1

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

IS - 12

ER -